XLO

XILIO THERAPEUTICS INC

XLO·98422T209·US·Common Stock-13D/G

XLO (XILIO THERAPEUTICS INC) is held by 11 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1M), MORGAN STANLEY ($483,516), RENAISSANCE TECHNOLOGIES LLC ($416,850). Net institutional sentiment: Bearish.

11
Holders
Avg rating(3 Elite)
$3M
Total Value
26% (23)
Fund Consensus
6 buying - 17 selling
XLOSmart Money Verdict
View all
Held by 11 funds
3 elite
Who's Trading
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.0.0%May 15, 2026
ActivistSISirenia Capital Management LP9.9%May 15, 2026
ActivistBIBCLS II Equity Opportunities, LP10.0%May 15, 2026
ActivistOAORBIMED ADVISORS LLC10.0%May 15, 2026
InsiderSSShannon James SamuelBuy $44KMar 26, 2026
ActivistSTStemPoint Capital LP8.4%Feb 17, 2026
ActivistBLBain Capital Life Sciences Fund II, L.P.1.3%Feb 17, 2026
InsiderSSShannon James SamuelBuy $17KJun 17, 2025
InsiderRRRusso ReneBuy $25KJun 16, 2025
InsiderSSShannon James SamuelBuy $31KJun 16, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
123,660$1M0.0%+1616.98%
38
Decreased
57,493(-93.2%)$483,5160.0%+984.24%
0
Decreased
49,566(-85.6%)$416,8500.0%+1089.39%
0
Decreased
37,197(-88.7%)$312,8480.0%+124.34%
0
Decreased
36,558(-92.9%)$307,4530.0%+838.14%
0
New
28,475$239,4750.0%+1616.98%
32
Decreased
13,311(-92.9%)$111,9460.0%+1007.19%
0
Increased
4,038(+1889.2%)$33,9600.0%+1616.98%
22
New
240$1,9760.0%+1616.98%
17
New
210$1,7660.0%+1616.98%
17
New
91$1,0000.0%+1616.98%
17
Exited
0(-100.0%)$12,0110.0%-45.36%
0
Exited
0(-100.0%)$16,0050.0%-30.26%
0
Exited
0(-100.0%)$39,7130.0%-30.66%
0
Exited
0(-100.0%)$1670.0%-41.25%
0
Exited
0(-100.0%)$13,4440.0%-22.06%
0
Exited
0(-100.0%)$11,0780.0%-31.86%
0
Exited
0(-100.0%)$1,3040.0%-45.36%
0
Exited
0(-100.0%)$42,6430.0%-86.38%
0
Exited
0(-100.0%)$279,2650.0%-18.46%
0

Showing 1-20 of 23

1 / 2

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used